Dr. Hönle AG (HNL) - Total Assets
Based on the latest financial reports, Dr. Hönle AG (HNL) holds total assets worth €142.00 Million EUR (≈ $166.02 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check HNL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Dr. Hönle AG - Total Assets Trend (2014–2025)
This chart illustrates how Dr. Hönle AG's total assets have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Dr. Hönle AG to see how much of total assets are deployed in long-term investments.
Dr. Hönle AG - Asset Composition Analysis
Current Asset Composition (September 2025)
Dr. Hönle AG's total assets of €142.00 Million consist of 36.6% current assets and 63.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.3% |
| Accounts Receivable | €13.81 Million | 9.5% |
| Inventory | €28.36 Million | 19.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.74 Million | 1.2% |
| Goodwill | €11.04 Million | 7.6% |
Asset Composition Trend (2014–2025)
This chart illustrates how Dr. Hönle AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Dr. Hönle AG worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dr. Hönle AG's current assets represent 36.6% of total assets in 2025, a decrease from 50.9% in 2014.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, down from 6.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 25.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 19.5% of total assets.
Dr. Hönle AG Competitors by Total Assets
Key competitors of Dr. Hönle AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bloom Energy Corp
NYSE:BE
|
USA | $4.66 Billion |
|
Ecopro BM. Co. Ltd
KQ:247540
|
Korea | ₩4.62 Trillion |
|
Chengdu Xuguang Electronics Co Ltd
SHG:600353
|
China | CN¥3.55 Billion |
|
Ningbo Ronbay New Energy Tech Ltd
SHG:688005
|
China | CN¥23.96 Billion |
|
Beijing Xinleineng Technology Co Ltd
SHE:300593
|
China | CN¥4.32 Billion |
|
Hubei Wanrun New Energy Technology Co. Ltd. A
SHG:688275
|
China | CN¥18.14 Billion |
|
East Group Co Ltd
SHE:300376
|
China | CN¥13.21 Billion |
|
WindSun Science & Technology Co. Ltd. A
SHG:688663
|
China | CN¥3.42 Billion |
Dr. Hönle AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.77 | 1.89 | 3.59 |
| Quick Ratio | 0.76 | 0.86 | 1.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €21.89 Million | €27.46 Million | €65.37 Million |
Dr. Hönle AG - Advanced Valuation Insights
This section examines the relationship between Dr. Hönle AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.74 |
| Latest Market Cap to Assets Ratio | 0.39 |
| Asset Growth Rate (YoY) | -6.4% |
| Total Assets | €145.52 Million |
| Market Capitalization | $57.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dr. Hönle AG's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dr. Hönle AG's assets decreased by 6.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dr. Hönle AG (2014–2025)
The table below shows the annual total assets of Dr. Hönle AG from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | €145.52 Million ≈ $170.12 Million |
-6.35% |
| 2024-09-30 | €155.38 Million ≈ $181.66 Million |
-11.79% |
| 2023-09-30 | €176.16 Million ≈ $205.94 Million |
-9.88% |
| 2022-09-30 | €195.46 Million ≈ $228.52 Million |
-3.67% |
| 2021-09-30 | €202.91 Million ≈ $237.22 Million |
+3.42% |
| 2020-09-30 | €196.20 Million ≈ $229.37 Million |
+36.11% |
| 2019-09-30 | €144.15 Million ≈ $168.52 Million |
+14.84% |
| 2018-09-30 | €125.52 Million ≈ $146.75 Million |
+22.69% |
| 2017-09-30 | €102.31 Million ≈ $119.61 Million |
+8.52% |
| 2016-09-30 | €94.28 Million ≈ $110.22 Million |
+3.59% |
| 2015-09-30 | €91.01 Million ≈ $106.40 Million |
+6.33% |
| 2014-09-30 | €85.59 Million ≈ $100.07 Million |
-- |
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives… Read more